EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Successful Use of Ranolazine in SCN5A p.R222Q–Related Multifocal Ectopic Purkinje‐Related Premature Contractions

Isabella Moreira Gonzalez Fonseca iD, Anna Terra França iD, André Assis Lopes do Carmo, Saskia N van der Crabben iD, Christian van der Werf, Arthur A M Wilde

Journal of Cardiovascular Electrophysiology · 2026-07 · 37 (7) · 1618-1622

DOI: 10.1111/jce.70371 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 20.05.2026. Verfasst von Isabella Moreira Gonzalez Fonseca und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. Hauptthemen laut MEDLINE: Ranolazine, Ventricular Premature Complexes, NAV1.5 Voltage-Gated Sodium Channel, Anti-Arrhythmia Agents. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gain‐of‐function variants in SCN5A may cause multifocal ectopic Purkinje‐related premature contractions (MEPPC), with a high premature ventricular contraction burden that may lead to PVC‐induced cardiomyopathy. Pharmacological therapy is usually required, as catheter ablation is ineffective because of the multifocal origin of the ectopy. Methods and Results We report two siblings with the pathogenic SCN5A p.Arg222Gln variant. In both, ranolazine markedly suppressed ventricular ectopy, improved or preserved left ventricular function, and enabled amiodarone withdrawal.

Conclusion

Ranolazine may represent a useful mechanism‐guided option for SCN5A‐related MEPPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RanolazineVentricular Premature ComplexesNAV1.5 Voltage-Gated Sodium ChannelAnti-Arrhythmia AgentsHeart RatePurkinje FibersHumansTreatment OutcomeFemaleMaleGenetic Predisposition to DiseasePhenotypeAction PotentialsPedigree

Stichwörter der Autor:innen

SCN5Ainherited arrhythmia syndromelate sodium current inhibitionmultifocal ectopic Purkinje‐related premature contractionsranolazine

Substanzen

RanolazineNAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, humanAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Department of Clinical Genetics, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Department of Cardiology, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.
  • Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, The Netherlands.

ORCID-Profile: Isabella Moreira Gonzalez Fonseca, Anna Terra França, Saskia N van der Crabben

Zitieren

APA

Fonseca, I. M. G., França, A. T., Carmo, A. A. L. D., van der Crabben, S. N., van der Werf, C., & Wilde, A. A. M. (2026). Successful Use of Ranolazine in SCN5A p.R222Q–Related Multifocal Ectopic Purkinje‐Related Premature Contractions. Journal of Cardiovascular Electrophysiology, 37(7), 1618-1622. https://doi.org/10.1111/jce.70371

Vancouver

Fonseca IMG, França AT, Carmo AALD, van der Crabben SN, van der Werf C, Wilde AAM. Successful Use of Ranolazine in SCN5A p.R222Q–Related Multifocal Ectopic Purkinje‐Related Premature Contractions. Journal of Cardiovascular Electrophysiology. 2026;37(7):1618-1622. doi:10.1111/jce.70371

BibTeX
@article{Fonseca2026,
  author = {Fonseca, Isabella Moreira Gonzalez and França, Anna Terra and Carmo, André Assis Lopes do and van der Crabben, Saskia N and van der Werf, Christian and Wilde, Arthur A M},
  title = {Successful Use of Ranolazine in SCN5A p.R222Q–Related Multifocal Ectopic Purkinje‐Related Premature Contractions},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  volume = {37},
  number = {7},
  pages = {1618--1622},
  doi = {10.1111/jce.70371}
}
Kostenlos starten →